Respirology

Article	Citations
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong	119
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact	98
One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis	80
COVID‐19 infection and the broader impacts of the pandemic on healthcare workers	71
ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma	60
Current global perspectives on silicosis—Convergence of old and newly emergent hazards	55
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	54
Natural history and mechanisms of COPD	53
Occupational COPD—The most under‐recognized occupational lung disease?	50
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand	46
Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA)	44
Air pollution and the pandemic: Long‐term PM2.5 exposure and disease severity in COVID‐19 patients	43
Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries	41
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery	39
Treatable traits in the NOVELTY study	39
Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis	36
Predictors of lung function trajectories in population‐based studies: A systematic review	36
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression	36
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis	35
Global Initiative for Asthma Strategy 2021	34
Outcomes of protracted bacterial bronchitis in children: A 5‐year prospective cohort study	34
Coagulation markers as predictors for clinical events in COPD	34
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	32
Lung cancer screening implementation: Complexities and priorities	30
Prevalence and burden of breathlessness in Australian adults: The National Breathlessness Survey—a cross‐sectional web‐based population survey	30

Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Austra	30
Delay or avoidance of routine, urgent and emergency medical care due to concerns about COVID‐19 in a region with low COVID‐19 prevalence: Victoria, Australia	29
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial	29
Epidemiology, clinical spectrum, viral kinetics and impact of COVID‐19 in the Asia‐Pacific region	29
Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort	28
Tocilizumab administration for the treatment of hospitalized patients with COVID‐19: A systematic review and meta‐analysis	27
Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype	26
Robotic‐assisted bronchoscopy versus CT‐guided transthoracic biopsy for diagnosis of pulmonary nodules	26
Abstracts	26
Pharmacological treatment of stable chronic obstructive pulmonary disease	26
Addition of zolpidem to combination therapy with atomoxetine‐oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial	25
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis	25
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	24
Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity	24
Mental health among healthcare workers during the COVID‐19 pandemic	23
Impact of early life exposures on COPD in adulthood: A systematic review and meta‐analysis	23
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	23
Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association	23
Effects of chemical composition on the lung cell response to coal particles: Implications for coal workers' pneumoconiosis	22
Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework	22
Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease	22
COVID‐19 situation in Pakistan: A broad overview	21
Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association*	21
Predictors of CPAP outcome in hospitalized COVID‐19 patients	21
Risk factors for chronic cough in adults: A systematic review and meta‐analysis	21
Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	21
COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography	21
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial	21
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases	20
Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study	20
Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry	20
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	19
Multiplanar 3D fluoroscopy redefines tool–lesion relationship during robotic‐assisted bronchoscopy	19
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden	19
Long‐term impact of coal mine fire smoke on lung mechanics in exposed adults	19
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations	18
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	18
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data	18
Effect of high‐flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial	17
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers	17
Defining successful non‐invasive ventilation initiation: Data from a real‐life cohort	17
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	17
Impact of COVID‐19 pandemic restrictions on the cardio‐respiratory health of New Zealanders	17
Ultrathin bronchoscopic cryobiopsy of peripheral pulmonary lesions	17
Delayed access to lung cancer screening and treatment during the COVID‐19 pandemic: Are we headed for a lung cancer pandemic?	17
Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019	16
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	16
Cryotherapy in the paediatric airway: Indications, success and safety	16
Central airway collapse is related to obesity independent of asthma phenotype	16
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	16

Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis	16
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis	15
Anti‐IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma	15
High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis	15
Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHANES 2011–2	15
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’	14
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort	14
Aerosol‐generating procedures in the COVID era	14
Biologics for severe asthma—Which, when and why?	14
Treatable traits for long COVID	14
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose	14
Letter from Indonesia	14
Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults	13
Pulmonary functional MRI: Detecting the structure–function pathologies that drive asthma symptoms and quality of life	13
Effect of surgical intervention for mild childhood obstructive sleep apnoea on attention and behavioural outcomes: A randomized controlled study	13
Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency	13
Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long‐term observational study	12
Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial	12
Robotic bronchoscopic needle‐based confocal laser endomicroscopy to diagnose peripheral lung nodules	12
IL‐17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus	12
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease	12
Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial	12
Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis	12
CPAP telemonitoring can track Cheyne–Stokes respiration and detect serious cardiac events: The AlertApnée Study	12
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia	11
Letter from Egypt	11
Genetic testing in interstitial lung disease: An international survey	11
Sleep‐disordered breathing was associated with lower health‐related quality of life and cognitive function in a cross‐sectional study of older adults	11
Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study	10
Contemporary narrative review of treatment options for COVID‐19	10
Increased physical activity reduces sleep disturbances in asthma: A randomized controlled trial	10
Radiological outcomes of whole lung lavage for artificial stone‐associated silicosis	10
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years	10
Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia	10
Periostin‐related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF‐2 signalling	10
Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates	10
Impact of recent catastrophic bushfires on people with asthma in Australia: Health, social and financial burdens	10
Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID‐19	10
Identifying the asthma research priorities of people with asthma, their carers and other stakeholders	10
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia	10
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	9
Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study	9
Value of adding ultrathin bronchoscopy to thin bronchoscopy for peripheral pulmonary lesions: A multicentre prospective study	9
Contemporary Concise Review 2021: Interstitial lung disease	9
Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease	9
Sleep and circadian health 6 months after critical COVID‐19 disease	9
Secondary infection among hospitalized COVID‐19 patients: A retrospective cohort study in a tertiary care setting	9
Cone‐beam computed tomography versus computed tomography‐guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score‐matched analysis	9
Cardiovascular risks of children with primary snoring: A 5‐year follow‐up study	9
Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial	9
Pulmonary fibrosis in non‐mutation carriers of families with short telomere syndrome gene mutations	9
Vocal cord dysfunction/inducible laryngeal obstruction—2022 Melbourne Roundtable Report	9
Thoracic manifestations of IgG4‐related disease	9
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population‐based cohort study	9
Examining the impact of multilevel upper airway surgery on the obstructive sleep apnoea endotypes and their utility in predicting surgical outcomes	9
Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial	9
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy	9
Bronchial thermoplasty: State of the art	8
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	8
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	8
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	8
Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score‐matched analysis using a nationwide	8
Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan	8
Inhaled corticosteroid is not associated with a poor prognosis in COVID‐19	8
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	8
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial	8
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF	8
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis	8
The HUNT study: Association of comorbidity clusters with long‐term survival and incidence of exacerbation in a population‐based Norwegian COPD cohort	8
Why we still need drugs for COVID‐19 and can't just rely on vaccines	8
Treatable traits models of care	7
Sarcoidosis‐related mortality and the impact of corticosteroid treatment: A population‐based cohort study	7
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	7
Covid‐19 pandemic and asthma: What did we learn?	7
Contemporary Concise Review 2020: Asthma	7
Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE‐2) Study	7
Prognosis assessment model based on low serum calcium in patients with acute pulmonary thromboembolism	7
Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival	7
Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire	7
Bronchiectasis enters the inflammation era	7

Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	7
Animal models of COVID‐19 hyper‐inflammation	7
Are e‐cigarette use and vaping associated with increased respiratory symptoms and poorer lung function in a population exposed to smoke from a coal mine fire?	7
The impact of regular bisoprolol on the response to salbutamol in asthma: A double‐blind randomized placebo‐controlled crossover trial	7
Asthma in developing countries in the Asia‐Pacific Region (APR)	7
Long‐term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia	7
Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations	7
Treatable traits, combination inhaler therapy and the future of asthma management	7
Comparisons of early and late presentation to hospital in COVID‐19 patients	7
Effect of obstructive sleep apnoea on coronary collateral vessel development in patients with ST‐segment elevation myocardial infarction	6
Causes of hypercapnic respiratory failure and associated in‐hospital mortality	6
Overexpression of SMAD7 improves the function of EGFR‐targeted human CAR‐T cells against non‐small‐cell lung cancer	6
Mobile cone‐beam computed tomography complementing shape‐sensing robotic‐assisted bronchoscopy in the small pulmonary nodule sampling: A multicentre experience	6
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision	6
Acute cigarette smoke‐induced eQTL affects formyl peptide receptor expression and lung function	6
Longitudinal effects of prenatal exposure to plastic‐derived chemicals and their metabolites on asthma and lung function from childhood into adulthood	6
Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion (AMPLE)‐2 randomized trial	6
Probe‐based confocal laser endomicroscopy for pleural malignancies diagnosis	6
COVID‐19 vaccine‐induced immunity: Head‐to‐head comparison of mRNA (BNT162b2) versus inactivated (CoronaVac) vaccines	6
Variations in lung cancer care and outcomes: How best to identify and improve standards of care?	6
Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient	6
Letter from Chile	6
Risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission during bronchoscopy in the intensive care unit	6
The needs and well‐being of severe asthma and COPD carers: A cross‐sectional study	6
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma	6
A low exhaled nitric oxide level excludes a short‐term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo‐controlled trial	6
Features of humidifier lung and comparison with summer‐type hypersensitivity pneumonitis	6
Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension	6
Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists	6
The potential impact of GLP‐1 agonists on obstructive sleep apnoea	5
CT in COPD: To be or not to be	5
Assessing spirometry competence through certification in community‐based healthcare settings in Australia and New Zealand: A position paper of the Australian and New Zealand Society of Respiratory Sci	5
Circulating regulators of the wingless pathway in precapillary pulmonary hypertension	5
Letter from China: Response after the first wave of COVID‐19	5
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	5
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	5
TSANZ Abstracts	5
Serum C‐reactive protein is associated with earlier mortality across different interstitial lung diseases	5
Social distancing as a strategy to prevent respiratory virus infections	5
Pulmonary vascular involvement in COVID‐19 pneumonitis: Is this the first and final insult?	5
Mapping air pollution and idiopathic pulmonary fibrosis	5
Antibiotic‐resistant bacteria: COVID‐19 hasn't made the challenge go away	5
Letter from China: Managing the second‐wave COVID‐19 outbreak in Beijing	5
Structural and functional changes in COPD: What we have learned from imaging	5
Alveolar crystal burden in stone workers with artificial stone silicosis	5
Dual bronchodilator treatment for prevention of COPD in at‐risk smokers	5
Choosing and switching biological agents in severe asthma	5
Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis	5
Growth of the airway smooth muscle layer from late gestation to childhood is mediated initially by hypertrophy and subsequently hyperplasia	5
Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic	5
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial	5
Bayesian adaptive clinical trial designs for respiratory medicine	5
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	5
Lung function in young adults born small for gestational age at term	4
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases	4
Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease	4
Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma	4
The impact of COVID‐19 on acute non‐invasive ventilation services: A case for change	4
Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics	4
Needle‐based confocal laser endomicroscopy for real‐time granuloma detection	4
Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics	4
A paediatric bronchoscopist's ‘Field of Dreams’: Will the flexible cryoprobe hit a home run?	4
Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines	4
Asthma and cardiovascular disease: A bidirectional association?	4
Ketogenic diet acutely improves gas exchange and sleep apnoea in obesity hypoventilation syndrome: A non‐randomized crossover study	4
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID‐19 admitted to hospital: An observational prospective study	4
Right ventricular end‐diastolic volume and outcomes in exacerbations of COPD	4
Effect of experimental modulation of mood on exertional dyspnoea in chronic obstructive pulmonary disease	4
Anti‐protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender‐related	4
Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement	4
The burden of systemic corticosteroid use in asthma management in Asia	4
Understanding the pathogenesis of engineered stone‐associated silicosis: The effect of particle chemistry on the lung cell response	4
The 1918 influenza and COVID‐19 pandemics: The effect of age on outcomes	4
Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis	4
Cardiovascular and cerebrovascular mortality in patients with preceding asthma exacerbation	4
Contemporary Concise Review 2022: Chronic obstructive pulmonary disease	4
Letter from South Africa—COVID‐19: The good, the bad and the ugly	4
Excess iron promotes emergence of foamy macrophages that overexpress ferritin in the lungs of silicosis patients	4
Multidisciplinary pulmonary embolism response team in China: A nationwide survey	4
A method to improve genetic analysis of lung cancer samples	4
Did you smoke? Addressing stigma in lung cancer	4
Attenuation of exertional desaturation and preference for interval exercise compared to continuous exercise in people with interstitial lung disease	4
PM2.5 exposure and risk of lung adenocarcinoma in women of Taiwan: A case–control study with density sampling	4
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure	4
Smoking induces shifts in cellular composition and transcriptome within the bronchial mucus barrier	3
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry	3
Eosinopenia is associated with adverse outcomes after COVID‐19 infection: A perspective from Japan	3
Longitudinal monitoring of asthma in the clinic using respiratory oscillometry	3
Contemporary Concise Review 2021: Pulmonary nodules from detection to intervention	3
Obesity is a major contributing cause of breathlessness in the population	3
Cardiac‐specific beta‐blockers and asthma: An end to fear?	3
Point of emission air filtration enhances protection of healthcare workers against skin contamination with virus aerosol	3
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	3
The global burden of respiratory infectious diseases before and beyond COVID	3
Long‐term effects of discontinuing renin–angiotensin system inhibitors in COVID‐19	3